Among these, UNC5B-AS1 was found to be a risk factor for poor osteosarcoma prognosis (Yang et al., 2022), promoting liver cancer cell migration, growth, and epithelial-mesenchymal transition (Huang et al., 2021), as well as exhibiting high expression levels in papillary thyroid carcinoma (Kim et al., 2022). This evidence concerns the gene UNC5B and differentiated thyroid carcinoma.